The European Lead Factory (ELF) - a drug discovery hub for validation new targets from academia and biotech...
Up To Date
Latest News
Transgène SA and AstraZeneca plc have entered into a collaboration and exclusive license option agreement on...
Liver specialist Alentis Therapeutics AG has raised CHF12.5m in a Series A round co-led by BioMedPartners and...
In its first meeting in Amsterdam, the CHMP of the European Medicines Agency recommended six new drugs, two...
Researchers at AstraZeneca, Viela Bio, Gilead Sciences, Antidote Therapeutics Inc., and at SoseiHeptares...
The US Patent Office has granted the Charpentier/Doudna key CRISPR patent, which was previously involved in an...
Share
